NASDAQ: CARECarter Bankshares Inc Stock
$33.32-0.28 (-0.83%)
Updated Jun 29, 2026
CARE Price
$33.32
Fair Value Price
$20.53
Market Cap
$740.44M
52 Week Low
$16.78
52 Week High
$33.87
P/E
6.84x
P/B
1.47x
P/S
1.97x
PEG
N/A
Dividend Yield
0.3%
Revenue
$258.92M
Earnings
$108.17M
Gross Margin
100%
Operating Margin
53.64%
Profit Margin
41.8%
Debt to Equity
8.51
Operating Cash Flow
$337M
Beta
0.75
Next Earnings
Jul 23, 2026
Ex-Dividend
N/A
Next Dividend
N/A
CARE Overview
Carter Bankshares, Inc. functions as the parent company for Carter Bank & Trust, delivering a comprehensive suite of banking solutions. It provides a variety of deposit accounts, including checking, savings, retirement, money market, and longer-term certificates of deposit. The institution also offers diverse loan products, such as secured and unsecured commercial loans, alongside consumer loans for purposes like auto financing, home improvements, education, overdraft protection, and personal investments. Additionally, it originates and holds residential mortgages (both fixed and variable rate), real estate construction and acquisition loans, home equity lines of credit, and credit cards. Beyond lending and deposits, Carter Bank & Trust furnishes other banking conveniences including safe deposit boxes, direct deposit services, extensive online and mobile banking capabilities (featuring bill pay, online account opening, and mobile deposit), debit cards, e-statements, and ATM access. The company further provides title insurance, various financial institution-related products, and treasury and corporate cash management services. Founded in 1974 and based in Martinsville, Virginia, Carter Bankshares, Inc. operates 69 branch locations spanning Virginia and North Carolina.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CARE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
CARE
Ranked#18 of 286
Ranked#18 of 286
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $92.50 | B | |
| $29.89 | B | |
| $56.30 | B |
Be the first to know about important CARE news, forecast changes, insider trades & much more!
CARE News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CARE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CARE ($33.32) is overvalued by 62.28% relative to our estimate of its Fair Value price of $20.53 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CARE ($33.32) is not significantly undervalued (62.28%) relative to our estimate of its Fair Value price of $20.53 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CARE is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CARE due diligence checks available for Premium users.
Valuation
CARE fair value
Fair Value of CARE stock based on Discounted Cash Flow (DCF)
Price
$33.32
Fair Value
$20.53
Overvalued by
62.28%
CARE ($33.32) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CARE ($33.32) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CARE is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CARE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.84x
Industry
13.51x
Market
10.71x
CARE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CARE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CARE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.47x
Industry
1.31x
CARE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CARE's financial health
Profit margin
Revenue
$141.0M
Net Income
$85.8M
Profit Margin
60.8%
CARE's Earnings (EBIT) of $138.90M... subscribe to Premium to read more.
Interest Coverage Financials
CARE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.8B
Liabilities
$4.3B
Debt to equity
8.51
CARE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CARE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$303.9M
Investing
-$26.6M
Financing
-$154.1M
CARE's operating cash flow ($337.40M)... subscribe to Premium to read more.
Debt Coverage Financials
CARE vs Bank Stocks
Carter Bankshares Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.